General - Press Releases

Date	Title	Company
12-Dec-2023	Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer	Businesswire
12-Dec-2023	Alomone Labs Collaborates With Bioz to Strengthen Research Capabilities Through the Innovative Integration of Scientific Citations	Newswire
12-Dec-2023	Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Young Blood Institute’s AmβARI study on Amyloid Removal	Businesswire
12-Dec-2023	L&T Technology Services and bp Sign Multi-Year Engineering Services Partnership	Businesswire
12-Dec-2023	Two Early Studies Evaluating Potential First-in-Class CELMoD™ Agent Golcadomide for the Treatment of Non-Hodgkin Lymphomas Presented at ASH 2023	Businesswire
12-Dec-2023	Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH	Businesswire
12-Dec-2023	Bristol Myers Squibb Announces Data at ASH 2023 from Diverse Multiple Myeloma Pipeline, Underscoring Range of Tailored Treatment Approaches to Address Unique Patient Needs	Businesswire
12-Dec-2023	Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)	Businesswire
12-Dec-2023	Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3	Businesswire
12-Dec-2023	Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition	Businesswire
12-Dec-2023	BioCT Names Dr. Stephen Bloch its 2023 Entrepreneur of the Year	Businesswire
12-Dec-2023	MedTech Innovator Crowns Medipixel Top 2023 Innovator in Grand Finals Competition of Asia Pacific Accelerator	Businesswire
12-Dec-2023	Maze Therapeutics Announces FTC Action Seeking to Block Collaboration and License Agreement with Sanofi Regarding MZE001, a Potential Oral Substrate Reduction Therapy for Pompe Disease	Businesswire
12-Dec-2023	SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1	Businesswire
11-Dec-2023	MedinCell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 19th, 2023	Businesswire
11-Dec-2023	Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year	Businesswire
11-Dec-2023	Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting	Businesswire
11-Dec-2023	MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023	Businesswire
11-Dec-2023	Data Analytics in Medical Devices Thematic Intelligence Report 2023: AI-Native Vendors Take Center Stage - ResearchAndMarkets.com	Businesswire
11-Dec-2023	Global Internet of Things (IoT) in Healthcare Thematic Intelligence Report 2023 - ResearchAndMarkets.com	Businesswire